David Sterman has been a financial researcher for more than 25 years. In the 1990's he got his start at Smith Barney, where he eventually became a Senior Analyst focused on the banking sector. He was the Director of Research at Individual Investor magazine in the latter half of the 1990's, and in the subsequent decade, worked at a pair of Connecticut-based hedged funds and also served as the Director of Research at Jesup & Lamont Securities. From 2009 through 2014, he was the Chief Market Strategist for StreetAuthority LLC, and currently focuses on sector-based research.
Numerous studies show that corporate carve outs deliver robust returns.
Shrinking the share count can have a strong impact on EPS growth.
A perfect storm is aligning in the bond market, but few are paying attention. Here's how to protect yourself.
Shares of Sprint have surged, despite a broken business model.
The biotech sector suffered a dismal 2016, but the longer-term outlook has rarely been brighter.
The dollar's surge has wreaked havoc on many developing economies. But these three stand out as potential winners this year and beyond.
There is a resurgence in profits, which means that it is time for a whole new investing playbook.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.